Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling

Resveratrol is known to be an effective chemo-preventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer treatment in oral cavity cancer. In this study, we investigated the oral antitumor activity of resveratrol and its mechanism in cisplatin-res...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of oncology Vol. 50; no. 3; pp. 873 - 882
Main Authors Chang, Chao-Hsiang, Lee, Chao-Ying, Lu, Chi-Cheng, Tsai, Fuu-Jen, Hsu, Yuan-Man, Tsao, Je-Wei, Juan, Yu-Ning, Chiu, Hong-Yi, Yang, Jai-Sing, Wang, Ching-Chiung
Format Journal Article
LanguageEnglish
Published Greece Spandidos Publications 01.03.2017
Spandidos Publications UK Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Resveratrol is known to be an effective chemo-preventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer treatment in oral cavity cancer. In this study, we investigated the oral antitumor activity of resveratrol and its mechanism in cisplatin-resistant human oral cancer CAR cells. Our results demonstrated that resveratrol had an extremely low toxicity in normal oral cells and provoked autophagic cell death to form acidic vesicular organelles (AVOs) and autophagic vacuoles in CAR cells by acridine orange (AO) and monodansylcadaverine (MDC) staining. Either DNA fragmentation or DNA condensation occurred in resveratrol-triggered CAR cell apoptosis. These inhibitors of PI3K class III (3-MA) and AMP-activated protein kinase (AMPK) (compound c) suppressed the autophagic vesicle formation, LC3-II protein levels and autophagy induced by resveratrol. The pan-caspase inhibitor Z-VAD-FMK attenuated resveratrol-triggered cleaved caspase-9, cleaved caspase-3 and cell apoptosis. Resveratrol also enhanced phosphorylation of AMPK and regulated autophagy- and pro-apoptosis-related signals in resveratrol-treated CAR cells. Importantly, resveratrol also stimulated the autophagic mRNA gene expression, including Atg5, Atg12, Beclin-1 and LC3-II in CAR cells. Overall, our findings indicate that resveratrol is likely to induce autophagic and apoptotic death in drug-resistant oral cancer cells and might become a new approach for oral cancer treatment in the near future.
AbstractList Resveratrol is known to be an effective chemopreventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer treatment in oral cavity cancer. In this study, we investigated the oral antitumor activity of resveratrol and its mechanism in cisplatin-resistant human oral cancer CAR cells. Our results demonstrated that resveratrol had an extremely low toxicity in normal oral cells and provoked autophagic cell death to form acidic vesicular organelles (AVOs) and autophagic vacuoles in CAR cells by acridine orange (AO) and monodansylcadaverine (MDC) staining. Either DNA fragmentation or DNA condensation occurred in resveratrol-triggered CAR cell apoptosis. These inhibitors of PI3K class III (3-MA) and AMP-activated protein kinase (AMPK) (compound c) suppressed the autophagic vesicle formation, LC3-II protein levels and autophagy induced by resveratrol. The pan-caspase inhibitor Z-VAD-FMK attenuated resveratrol-triggered cleaved caspase-9, cleaved caspase-3 and cell apoptosis. Resveratrol also enhanced phosphorylation of AMPK and regulated autophagy- and pro-apoptosis-related signals in resveratrol-treated CAR cells. Importantly, resveratrol also stimulated the autophagic mRNA gene expression, including Atg5, Atg12, Beclin-1 and LC3-II in CAR cells. Overall, our findings indicate that resveratrol is likely to induce autophagic and apoptotic death in drug-resistant oral cancer cells and might become a new approach for oral cancer treatment in the near future.
Resveratrol is known to be an effective chemo-preventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer treatment in oral cavity cancer. In this study, we investigated the oral antitumor activity of resveratrol and its mechanism in cisplatin-resistant human oral cancer CAR cells. Our results demonstrated that resveratrol had an extremely low toxicity in normal oral cells and provoked autophagic cell death to form acidic vesicular organelles (AVOs) and autophagic vacuoles in CAR cells by acridine orange (AO) and monodansylcadaverine (MDC) staining. Either DNA fragmentation or DNA condensation occurred in resveratrol-triggered CAR cell apoptosis. These inhibitors of PI3K class III (3-MA) and AMP-activated protein kinase (AMPK) (compound c) suppressed the autophagic vesicle formation, LC3-II protein levels and autophagy induced by resveratrol. The pan-caspase inhibitor Z-VAD-FMK attenuated resveratrol-triggered cleaved caspase-9, cleaved caspase-3 and cell apoptosis. Resveratrol also enhanced phosphorylation of AMPK and regulated autophagy- and pro-apoptosis-related signals in resveratrol-treated CAR cells. Importantly, resveratrol also stimulated the autophagic mRNA gene expression, including Atg5, Atg12, Beclin-1 and LC3-II in CAR cells. Overall, our findings indicate that resveratrol is likely to induce autophagic and apoptotic death in drug-resistant oral cancer cells and might become a new approach for oral cancer treatment in the near future.
Audience Academic
Author Hsu, Yuan-Man
Chang, Chao-Hsiang
Wang, Ching-Chiung
Tsao, Je-Wei
Yang, Jai-Sing
Lee, Chao-Ying
Juan, Yu-Ning
Lu, Chi-Cheng
Chiu, Hong-Yi
Tsai, Fuu-Jen
Author_xml – sequence: 1
  givenname: Chao-Hsiang
  surname: Chang
  fullname: Chang, Chao-Hsiang
– sequence: 2
  givenname: Chao-Ying
  surname: Lee
  fullname: Lee, Chao-Ying
– sequence: 3
  givenname: Chi-Cheng
  surname: Lu
  fullname: Lu, Chi-Cheng
– sequence: 4
  givenname: Fuu-Jen
  surname: Tsai
  fullname: Tsai, Fuu-Jen
– sequence: 5
  givenname: Yuan-Man
  surname: Hsu
  fullname: Hsu, Yuan-Man
– sequence: 6
  givenname: Je-Wei
  surname: Tsao
  fullname: Tsao, Je-Wei
– sequence: 7
  givenname: Yu-Ning
  surname: Juan
  fullname: Juan, Yu-Ning
– sequence: 8
  givenname: Hong-Yi
  surname: Chiu
  fullname: Chiu, Hong-Yi
– sequence: 9
  givenname: Jai-Sing
  surname: Yang
  fullname: Yang, Jai-Sing
– sequence: 10
  givenname: Ching-Chiung
  surname: Wang
  fullname: Wang, Ching-Chiung
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28197628$$D View this record in MEDLINE/PubMed
BookMark eNp1kktv1DAUhS1URB-wZIssIbHLNHYcJ2YXjUpBFBWNytryODcznjp2sB2k-Qn863poeRSBvLDv1XePj3TPKTpy3gFCL0m5qFpBz83OL2hJmlxx_gSdkEaQgjJaHeV3SUTBWSWO0WmMu7KkdV2SZ-iYtkQ0nLYn6PsK4jcIKgVvC-P6WUOP1Zz8tFWbPVYuV5Ofko8mYuOwNnGyKhlXBMitpFzC23lUDvugLNbKaQh42a2wBmvjW9zhW9jjrA7YD7j79PnjD9HuNp2PN9crHM3GKWvc5jl6Oigb4cXDfYa-vLu4Wb4vrq4vPyy7q0LXlKWCQ9X0ABWj_bquQRExcE5rogmIHhoN0JQNJz0RayUYJe3Qs4YrUmvOWE-r6gy9vtedgv86Q0xy5-eQPURJRN1wJijnv6mNsiCNG3wKSo8matkxQUjdlC3N1OIfVD49jEbnRQ0m9x8NvPljYAvKpm30dk7Gu_gYfPXgcl6P0MspmFGFvfy5uQwU94AOPsYAwy-ElPKQDJmTIQ_JkIdkZL76i9cmqcO_2bKx_5m6A96CulY
CitedBy_id crossref_primary_10_1016_j_ejphar_2019_04_001
crossref_primary_10_3390_ph14100982
crossref_primary_10_52679_tabcj_2023_0002
crossref_primary_10_1016_j_phrs_2022_106398
crossref_primary_10_1016_j_lfs_2018_06_028
crossref_primary_10_1186_s12645_024_00274_2
crossref_primary_10_1124_molpharm_121_000481
crossref_primary_10_1016_j_carbpol_2019_115171
crossref_primary_10_3892_ijmm_2018_3857
crossref_primary_10_1016_j_ejphar_2020_173657
crossref_primary_10_1016_j_semcancer_2018_09_005
crossref_primary_10_2478_acph_2022_0025
crossref_primary_10_1016_j_ccr_2020_213640
crossref_primary_10_1016_j_ejphar_2020_173534
crossref_primary_10_3168_jds_2019_17173
crossref_primary_10_1186_s12943_024_01934_y
crossref_primary_10_1016_j_bbamcr_2023_119537
crossref_primary_10_2174_1871520619666191015104458
crossref_primary_10_4236_ym_2021_51002
crossref_primary_10_1002_jsfa_13664
crossref_primary_10_1158_0008_5472_CAN_18_2738
crossref_primary_10_3390_ijms20174279
crossref_primary_10_1038_s41419_018_1126_4
crossref_primary_10_1016_j_phrs_2024_107099
crossref_primary_10_2174_1566524023666230817102114
crossref_primary_10_1007_s43440_021_00223_5
crossref_primary_10_3892_ijo_2020_5107
crossref_primary_10_1002_tox_22769
crossref_primary_10_3892_mmr_2018_8402
crossref_primary_10_11620_IJOB_2020_45_3_115
crossref_primary_10_18632_oncotarget_15477
crossref_primary_10_1007_s12094_021_02770_y
crossref_primary_10_1038_s41388_020_1329_x
crossref_primary_10_1002_ptr_7608
crossref_primary_10_1093_jpp_rgac056
crossref_primary_10_1016_j_cca_2018_11_028
crossref_primary_10_1016_j_envres_2023_116432
crossref_primary_10_2174_1566524020666200521080953
crossref_primary_10_3390_cancers14194625
crossref_primary_10_1155_2019_5213028
crossref_primary_10_1007_s12032_021_01548_0
crossref_primary_10_1016_j_ejphar_2017_08_037
crossref_primary_10_3390_nu14030699
crossref_primary_10_2174_0929867327999200918100746
crossref_primary_10_1111_odi_15293
crossref_primary_10_17135_jdhs_2018_18_3_188
crossref_primary_10_2174_0929867329666220729153654
crossref_primary_10_1002_jcb_26822
crossref_primary_10_3390_molecules27092665
crossref_primary_10_1111_bcpt_14110
crossref_primary_10_1016_j_pharmthera_2017_10_012
crossref_primary_10_1080_01635581_2021_1931698
crossref_primary_10_1128_AAC_01233_18
crossref_primary_10_2174_1874467215666220415131344
crossref_primary_10_32604_biocell_2021_015608
crossref_primary_10_1080_14756366_2023_2276665
crossref_primary_10_23902_trkjnat_999403
crossref_primary_10_3390_molecules28010251
crossref_primary_10_1038_s41598_020_62292_5
crossref_primary_10_4103_jcrt_JCRT_963_19
crossref_primary_10_1007_s11095_025_03836_0
crossref_primary_10_13005_bpj_2890
crossref_primary_10_3390_ijms21093285
crossref_primary_10_1186_s11658_021_00301_9
crossref_primary_10_1016_j_jconrel_2020_11_047
crossref_primary_10_1186_s43094_020_00161_8
crossref_primary_10_3389_fonc_2019_00769
crossref_primary_10_3389_fphar_2020_00343
crossref_primary_10_3390_antiox10010123
crossref_primary_10_1002_adtp_202400197
crossref_primary_10_3390_biom15030326
crossref_primary_10_1016_j_phymed_2021_153554
crossref_primary_10_3390_cancers15184499
crossref_primary_10_1016_j_jfda_2018_01_006
crossref_primary_10_3390_nu12061750
crossref_primary_10_3390_ijms23158813
crossref_primary_10_1016_j_yexmp_2020_104367
crossref_primary_10_3390_cancers12113461
crossref_primary_10_1007_s12079_022_00711_0
crossref_primary_10_1002_jssc_202200522
crossref_primary_10_1111_and_14267
crossref_primary_10_1002_iid3_70041
crossref_primary_10_1016_j_biopha_2018_01_163
crossref_primary_10_1002_ptr_8228
crossref_primary_10_1016_j_lfs_2018_07_035
crossref_primary_10_1016_j_semcancer_2017_08_005
crossref_primary_10_1134_S000635092006010X
crossref_primary_10_3389_fmolb_2021_649395
crossref_primary_10_3892_or_2017_5811
crossref_primary_10_1042_BSR20192102
crossref_primary_10_1186_s12903_024_04045_8
crossref_primary_10_1111_jfbc_13666
crossref_primary_10_1111_jcmm_13825
crossref_primary_10_1051_bmdcn_2017070205
crossref_primary_10_1002_ptr_7082
crossref_primary_10_1186_s12935_022_02719_3
crossref_primary_10_3390_molecules22081329
crossref_primary_10_1051_bmdcn_2017070201
crossref_primary_10_1007_s10495_021_01689_7
crossref_primary_10_1016_j_ijbiomac_2019_09_093
crossref_primary_10_1016_j_tice_2023_102071
crossref_primary_10_1007_s12032_023_02237_w
crossref_primary_10_1089_adt_2020_972
crossref_primary_10_1002_mnfr_202100732
crossref_primary_10_1042_CS20200310
crossref_primary_10_1590_1678_4685_gmb_2020_0014
crossref_primary_10_1016_j_bcp_2021_114454
crossref_primary_10_3389_fphar_2021_710304
crossref_primary_10_3389_froh_2023_1246873
crossref_primary_10_3390_app11031259
crossref_primary_10_1016_j_phymed_2024_156127
crossref_primary_10_2139_ssrn_3993289
crossref_primary_10_1016_j_biopha_2022_113274
crossref_primary_10_1016_j_phrs_2024_107381
crossref_primary_10_1038_s41423_024_01253_8
crossref_primary_10_1080_21691401_2019_1623232
crossref_primary_10_3390_ijms232213689
crossref_primary_10_1093_abbs_gmab042
crossref_primary_10_3390_biom12111565
crossref_primary_10_1016_j_intimp_2022_108806
crossref_primary_10_3390_antiox14030339
crossref_primary_10_3390_ijms21186635
crossref_primary_10_3390_cells8020138
crossref_primary_10_1016_j_molstruc_2024_140149
crossref_primary_10_1039_D4NR01483A
crossref_primary_10_1002_ptr_8202
crossref_primary_10_1016_j_semcancer_2020_10_010
crossref_primary_10_3389_fphar_2024_1348076
crossref_primary_10_1002_jcb_26905
crossref_primary_10_1016_j_biopha_2019_108703
crossref_primary_10_1038_s41419_018_1194_5
crossref_primary_10_3390_ijms18091959
crossref_primary_10_2174_1389450121666200504072635
crossref_primary_10_3390_md16070238
crossref_primary_10_3389_fphar_2021_748149
crossref_primary_10_1002_jcp_28774
crossref_primary_10_3390_molecules25225254
crossref_primary_10_1016_j_canlet_2024_216659
crossref_primary_10_3390_plants12122330
crossref_primary_10_1080_10408398_2022_2101428
crossref_primary_10_1007_s11427_020_1978_4
crossref_primary_10_1177_03946320221125090
crossref_primary_10_3892_or_2017_5988
Cites_doi 10.1111/nyas.12883
10.1038/cdd.2013.84
10.1016/j.bbagen.2016.01.017
10.1016/j.fct.2008.10.032
10.1016/j.taap.2013.03.007
10.1093/carcin/bgm271
10.1097/CEJ.0b013e328360345f
10.2147/DDDT.S67961
10.3892/or.2015.4407
10.3389/fnut.2016.00008
10.1371/journal.pone.0047049
10.1007/s12253-014-9794-6
10.1038/cddis.2013.350
10.4161/auto.7.5.14226
10.18632/oncotarget.384
10.1016/j.canlet.2013.11.001
10.1158/1078-0432.CCR-10-1486
10.18632/oncotarget.6986
10.1007/s00784-016-1736-0
10.1038/nrm1666
10.1016/j.semcancer.2016.09.001
10.1002/ijc.23721
10.1371/journal.pone.0161017
10.7603/s40681-015-0023-8
10.1371/journal.pone.0094941
10.1073/pnas.94.25.14138
10.1126/science.275.5297.218
10.1016/j.biocel.2009.06.003
10.3892/ijo.2014.2478
10.1016/j.fct.2012.01.033
10.1002/mnfr.201400051
10.1016/j.bbagen.2014.02.022
10.1053/j.gastro.2012.02.050
10.1080/01926230701320337
10.1371/journal.pone.0084175
10.1146/annurev-genet-102808-114910
10.1039/c0ib00144a
10.1002/jcb.24997
10.3892/ijo.2013.2050
10.1016/j.oraloncology.2016.09.001
10.1021/jf9036694
10.1111/j.1442-2042.2012.03024.x
10.1002/mnfr.201000005
10.1038/srep17730
10.1371/journal.pone.0129196
10.1007/s13238-014-0089-1
10.1002/mc.22324
10.1371/journal.pone.0102535
10.1016/j.freeradbiomed.2014.10.750
10.3892/ijo.2012.1325
10.1038/ncb2152
10.1016/S0009-9120(96)00155-5
10.3390/ijms15023145
10.1016/j.canlet.2015.11.032
ContentType Journal Article
Copyright COPYRIGHT 2017 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2017
Copyright_xml – notice: COPYRIGHT 2017 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.3892/ijo.2017.3866
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList ProQuest One Academic Middle East (New)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-2423
EndPage 882
ExternalDocumentID A491157082
28197628
10_3892_ijo_2017_3866
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
0R~
2WC
53G
5GY
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAYXX
ABJNI
ABPMR
ABUWG
ACGFO
ACGFS
ADBBV
AEGXH
AENEX
AFKRA
AFOSN
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
BAWUL
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
EMOBN
F5P
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
IHW
INH
INR
IPNFZ
ITC
L7B
M1P
NAPCQ
O9-
ODZKP
OGEVE
OK1
OVD
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
RIG
SV3
TEORI
TR2
UDS
UKHRP
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c524t-6e37dee342db55ea19f66251c1e9de7cee70761d19ba94218fd476a15c644d233
IEDL.DBID 7X7
ISSN 1019-6439
IngestDate Fri Jul 25 06:42:59 EDT 2025
Tue Jun 17 21:40:16 EDT 2025
Tue Jun 10 20:20:47 EDT 2025
Thu May 22 21:16:52 EDT 2025
Thu Jan 02 22:31:21 EST 2025
Tue Jul 01 03:20:49 EDT 2025
Thu Apr 24 22:52:57 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c524t-6e37dee342db55ea19f66251c1e9de7cee70761d19ba94218fd476a15c644d233
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink http://www.spandidos-publications.com/10.3892/ijo.2017.3866/download
PMID 28197628
PQID 1957649266
PQPubID 2044957
PageCount 10
ParticipantIDs proquest_journals_1957649266
gale_infotracmisc_A491157082
gale_infotracacademiconefile_A491157082
gale_healthsolutions_A491157082
pubmed_primary_28197628
crossref_primary_10_3892_ijo_2017_3866
crossref_citationtrail_10_3892_ijo_2017_3866
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-03-01
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle International journal of oncology
PublicationTitleAlternate Int J Oncol
PublicationYear 2017
Publisher Spandidos Publications
Spandidos Publications UK Ltd
Publisher_xml – name: Spandidos Publications
– name: Spandidos Publications UK Ltd
References Hsieh (key20180107175716_b13-ijo-50-03-0873) 2014; 45
Shih (key20180107175716_b26-ijo-50-03-0873) 2014; 9
Ma (key20180107175716_b28-ijo-50-03-0873) 2012; 50
Baehrecke (key20180107175716_b12-ijo-50-03-0873) 2005; 6
Chiang (key20180107175716_b29-ijo-50-03-0873) 2013; 269
Adhauliya (key20180107175716_b14-ijo-50-03-0873) 2016; 61
Lu (key20180107175716_b27-ijo-50-03-0873) 2014; 58
Zhu (key20180107175716_b51-ijo-50-03-0873) 2013; 8
Selvaraj (key20180107175716_b38-ijo-50-03-0873) 2016; 55
Gwak (key20180107175716_b33-ijo-50-03-0873) 2016; 371
Miki (key20180107175716_b45-ijo-50-03-0873) 2012; 40
Alayev (key20180107175716_b39-ijo-50-03-0873) 2015; 116
Gosepath (key20180107175716_b24-ijo-50-03-0873) 2008; 123
Zhao (key20180107175716_b48-ijo-50-03-0873) 2014; 8
Yuan (key20180107175716_b30-ijo-50-03-0873) 2016
Shen (key20180107175716_b3-ijo-50-03-0873) 2011; 7
Kim (key20180107175716_b50-ijo-50-03-0873) 2011; 13
Pereira (key20180107175716_b5-ijo-50-03-0873) 2015; 21
Lin (key20180107175716_b40-ijo-50-03-0873) 2012; 19
Kong (key20180107175716_b10-ijo-50-03-0873) 2015; 1350
Liu (key20180107175716_b54-ijo-50-03-0873) 2012; 7
Subramanian (key20180107175716_b22-ijo-50-03-0873) 2010; 16
Yeh (key20180107175716_b8-ijo-50-03-0873) 2016; 20
Jang (key20180107175716_b21-ijo-50-03-0873) 1997; 275
Plati (key20180107175716_b2-ijo-50-03-0873) 2011; 3
Yang (key20180107175716_b55-ijo-50-03-0873) 2009; 47
Gehm (key20180107175716_b19-ijo-50-03-0873) 1997; 94
Inoue (key20180107175716_b1-ijo-50-03-0873) 2014; 21
Yuan (key20180107175716_b35-ijo-50-03-0873) 2016; 35
Lu (key20180107175716_b32-ijo-50-03-0873) 2014; 1840
Huang (key20180107175716_b6-ijo-50-03-0873) 2010; 54
Ho (key20180107175716_b9-ijo-50-03-0873) 2015; 5
Mancias (key20180107175716_b46-ijo-50-03-0873) 2011; 2
Din (key20180107175716_b53-ijo-50-03-0873) 2012; 142
Marques (key20180107175716_b18-ijo-50-03-0873) 2009; 41
Soleas (key20180107175716_b23-ijo-50-03-0873) 1997; 30
He (key20180107175716_b47-ijo-50-03-0873) 2009; 43
Button (key20180107175716_b42-ijo-50-03-0873) 2016; 7
Jiang (key20180107175716_b52-ijo-50-03-0873) 2016; 11
García-Zepeda (key20180107175716_b44-ijo-50-03-0873) 2013; 22
Dandawate (key20180107175716_b20-ijo-50-03-0873) 2016; 40–41
Varoni (key20180107175716_b16-ijo-50-03-0873) 2016; 3
Crek (key20180107175716_b36-ijo-50-03-0873) 2014; 75
Li (key20180107175716_b49-ijo-50-03-0873) 2014; 344
Zhu (key20180107175716_b37-ijo-50-03-0873) 2015; 5
Chang (key20180107175716_b25-ijo-50-03-0873) 2013; 43
Elmore (key20180107175716_b43-ijo-50-03-0873) 2007; 35
Trincheri (key20180107175716_b41-ijo-50-03-0873) 2008; 29
Sui (key20180107175716_b15-ijo-50-03-0873) 2013; 4
Shimizu (key20180107175716_b4-ijo-50-03-0873) 2014; 15
Lang (key20180107175716_b34-ijo-50-03-0873) 2015; 10
Xiong (key20180107175716_b7-ijo-50-03-0873) 2014; 5
de Oliveira (key20180107175716_b17-ijo-50-03-0873) 2016; 1860
Fu (key20180107175716_b11-ijo-50-03-0873) 2014; 9
Lai (key20180107175716_b31-ijo-50-03-0873) 2010; 58
References_xml – volume: 1350
  start-page: 1
  year: 2015
  ident: key20180107175716_b10-ijo-50-03-0873
  article-title: Mitochondrial dynamics regulating chemoresistance in gynecological cancers
  publication-title: Ann NY Acad Sci
  doi: 10.1111/nyas.12883
– volume: 21
  start-page: 39
  year: 2014
  ident: key20180107175716_b1-ijo-50-03-0873
  article-title: Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2013.84
– volume: 1860
  start-page: 727
  year: 2016
  ident: key20180107175716_b17-ijo-50-03-0873
  article-title: Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2016.01.017
– volume: 47
  start-page: 171
  year: 2009
  ident: key20180107175716_b55-ijo-50-03-0873
  article-title: Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases casade and mitochondrial-dependent pathways
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2008.10.032
– volume: 269
  start-page: 150
  year: 2013
  ident: key20180107175716_b29-ijo-50-03-0873
  article-title: Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2013.03.007
– volume: 29
  start-page: 381
  year: 2008
  ident: key20180107175716_b41-ijo-50-03-0873
  article-title: Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgm271
– volume: 22
  start-page: 577
  year: 2013
  ident: key20180107175716_b44-ijo-50-03-0873
  article-title: Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0b013e328360345f
– volume: 8
  start-page: 1827
  year: 2014
  ident: key20180107175716_b48-ijo-50-03-0873
  article-title: Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
  publication-title: Drug Des Devel Ther
  doi: 10.2147/DDDT.S67961
– volume: 35
  start-page: 939
  year: 2016
  ident: key20180107175716_b35-ijo-50-03-0873
  article-title: BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.4407
– volume: 3
  start-page: 8
  year: 2016
  ident: key20180107175716_b16-ijo-50-03-0873
  article-title: Anticancer molecular mechanisms of resveratrol
  publication-title: Front Nutr
  doi: 10.3389/fnut.2016.00008
– volume: 7
  start-page: e47049
  year: 2012
  ident: key20180107175716_b54-ijo-50-03-0873
  article-title: Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0047049
– volume: 21
  start-page: 103
  year: 2015
  ident: key20180107175716_b5-ijo-50-03-0873
  article-title: Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer
  publication-title: Pathol Oncol Res
  doi: 10.1007/s12253-014-9794-6
– volume: 4
  start-page: e838
  year: 2013
  ident: key20180107175716_b15-ijo-50-03-0873
  article-title: Autophagy and chemotherapy resistance: A promising therapeutic target for cancer treatment
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2013.350
– volume: 7
  start-page: 457
  year: 2011
  ident: key20180107175716_b3-ijo-50-03-0873
  article-title: Autophagic cell death: Loch Ness monster or endangered species?
  publication-title: Autophagy
  doi: 10.4161/auto.7.5.14226
– volume: 2
  start-page: 1302
  year: 2011
  ident: key20180107175716_b46-ijo-50-03-0873
  article-title: Targeting autophagy addiction in cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.384
– volume: 344
  start-page: 239
  year: 2014
  ident: key20180107175716_b49-ijo-50-03-0873
  article-title: Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.11.001
– volume: 16
  start-page: 5942
  year: 2010
  ident: key20180107175716_b22-ijo-50-03-0873
  article-title: Resveratrol: challenges in translation to the clinic - a critical discussion
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-10-1486
– volume: 7
  start-page: 5157
  year: 2016
  ident: key20180107175716_b42-ijo-50-03-0873
  article-title: Dual PI-3 kinase/mTOR inhibition impairs autophagy flux and induces cell death independent of apoptosis and necroptosis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6986
– volume: 20
  start-page: 2343
  year: 2016
  ident: key20180107175716_b8-ijo-50-03-0873
  article-title: Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts
  publication-title: Clin Oral Investig
  doi: 10.1007/s00784-016-1736-0
– volume: 6
  start-page: 505
  year: 2005
  ident: key20180107175716_b12-ijo-50-03-0873
  article-title: Autophagy: Dual roles in life and death?
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm1666
– volume: 40–41
  start-page: 192
  year: 2016
  ident: key20180107175716_b20-ijo-50-03-0873
  article-title: Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2016.09.001
– volume: 123
  start-page: 2013
  year: 2008
  ident: key20180107175716_b24-ijo-50-03-0873
  article-title: Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23721
– volume: 11
  start-page: e0161017
  year: 2016
  ident: key20180107175716_b52-ijo-50-03-0873
  article-title: GSK621 targets glioma cells via activating AMP-activated protein kinase signalings
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0161017
– volume: 5
  start-page: 23
  year: 2015
  ident: key20180107175716_b9-ijo-50-03-0873
  article-title: A promising 'TRAIL' of tanshinones for cancer therapy
  publication-title: Biomedicine (Taipei)
  doi: 10.7603/s40681-015-0023-8
– volume: 9
  start-page: e94941
  year: 2014
  ident: key20180107175716_b26-ijo-50-03-0873
  article-title: Evaluation physical characteristics and comparison antimicrobial and anti-inflammation potentials of dental root canal sealers containing hinokitiol in vitro
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0094941
– volume: 94
  start-page: 14138
  year: 1997
  ident: key20180107175716_b19-ijo-50-03-0873
  article-title: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.94.25.14138
– volume: 275
  start-page: 218
  year: 1997
  ident: key20180107175716_b21-ijo-50-03-0873
  article-title: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
  publication-title: Science
  doi: 10.1126/science.275.5297.218
– volume: 41
  start-page: 2125
  year: 2009
  ident: key20180107175716_b18-ijo-50-03-0873
  article-title: Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2009.06.003
– volume: 45
  start-page: 782
  year: 2014
  ident: key20180107175716_b13-ijo-50-03-0873
  article-title: The novel pterostilbene derivative ANK-199 induces autophagic cell death through regulating PI3 kinase class III/beclin 1/Atg-related proteins in cisplatin-resistant CAR human oral cancer cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2014.2478
– volume: 50
  start-page: 1271
  year: 2012
  ident: key20180107175716_b28-ijo-50-03-0873
  article-title: Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts model
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2012.01.033
– volume: 58
  start-page: 2146
  year: 2014
  ident: key20180107175716_b27-ijo-50-03-0873
  article-title: Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201400051
– volume: 1840
  start-page: 2310
  year: 2014
  ident: key20180107175716_b32-ijo-50-03-0873
  article-title: Cell death caused by quinazolinone HMJ-38 challenge in oral carcinoma CAL 27 cells: Dissections of endoplasmic reticulum stress, mitochondrial dysfunction and tumor xenografts
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2014.02.022
– volume: 142
  start-page: 1504
  year: 2012
  ident: key20180107175716_b53-ijo-50-03-0873
  article-title: Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2012.02.050
– volume: 35
  start-page: 495
  year: 2007
  ident: key20180107175716_b43-ijo-50-03-0873
  article-title: Apoptosis: A review of programmed cell death
  publication-title: Toxicol Pathol
  doi: 10.1080/01926230701320337
– volume: 8
  start-page: e84175
  year: 2013
  ident: key20180107175716_b51-ijo-50-03-0873
  article-title: Salinomycin activates AMP-activated protein kinase-dependent autophagy in cultured osteoblastoma cells: A negative regulator against cell apoptosis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0084175
– volume: 43
  start-page: 67
  year: 2009
  ident: key20180107175716_b47-ijo-50-03-0873
  article-title: Regulation mechanisms and signaling pathways of autophagy
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-102808-114910
– volume: 3
  start-page: 279
  year: 2011
  ident: key20180107175716_b2-ijo-50-03-0873
  article-title: Apoptotic cell signaling in cancer progression and therapy
  publication-title: Integr Biol
  doi: 10.1039/c0ib00144a
– volume: 116
  start-page: 450
  year: 2015
  ident: key20180107175716_b39-ijo-50-03-0873
  article-title: The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.24997
– volume: 43
  start-page: 1141
  year: 2013
  ident: key20180107175716_b25-ijo-50-03-0873
  article-title: Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2013.2050
– volume: 61
  start-page: 120
  year: 2016
  ident: key20180107175716_b14-ijo-50-03-0873
  article-title: Autophagy: A boon or bane in oral cancer
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2016.09.001
– volume: 58
  start-page: 2935
  year: 2010
  ident: key20180107175716_b31-ijo-50-03-0873
  article-title: Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway
  publication-title: J Agric Food Chem
  doi: 10.1021/jf9036694
– volume: 19
  start-page: 757
  year: 2012
  ident: key20180107175716_b40-ijo-50-03-0873
  article-title: Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells
  publication-title: Int J Urol
  doi: 10.1111/j.1442-2042.2012.03024.x
– volume: 54
  start-page: 1585
  year: 2010
  ident: key20180107175716_b6-ijo-50-03-0873
  article-title: Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201000005
– volume: 5
  start-page: 17730
  year: 2015
  ident: key20180107175716_b37-ijo-50-03-0873
  article-title: Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells
  publication-title: Sci Rep
  doi: 10.1038/srep17730
– volume: 10
  start-page: e0129196
  year: 2015
  ident: key20180107175716_b34-ijo-50-03-0873
  article-title: Apoptotic cell death induced by resveratrol is partially mediated by the autophagy pathway in human ovarian cancer cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0129196
– volume: 5
  start-page: 737
  year: 2014
  ident: key20180107175716_b7-ijo-50-03-0873
  article-title: Mitochondria-mediated apoptosis in mammals
  publication-title: Protein Cell
  doi: 10.1007/s13238-014-0089-1
– volume: 55
  start-page: 818
  year: 2016
  ident: key20180107175716_b38-ijo-50-03-0873
  article-title: Resveratrol activates autophagic cell death in prostate cancer cells via down-regulation of STIM1 and the mTOR pathway
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22324
– volume: 9
  start-page: e102535
  year: 2014
  ident: key20180107175716_b11-ijo-50-03-0873
  article-title: Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0102535
– volume: 75
  start-page: S27
  issue: Suppl 1
  year: 2014
  ident: key20180107175716_b36-ijo-50-03-0873
  article-title: The effect of resveratrol on signal transduction pathways and the role of pro-apoptotic Bax protein on apoptosis in HCT-116 colon carcinoma cell lines
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2014.10.750
– year: 2016
  ident: key20180107175716_b30-ijo-50-03-0873
  article-title: Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling
  publication-title: Environ Toxicol
– volume: 40
  start-page: 1020
  year: 2012
  ident: key20180107175716_b45-ijo-50-03-0873
  article-title: Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2012.1325
– volume: 13
  start-page: 132
  year: 2011
  ident: key20180107175716_b50-ijo-50-03-0873
  article-title: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2152
– volume: 30
  start-page: 91
  year: 1997
  ident: key20180107175716_b23-ijo-50-03-0873
  article-title: Resveratrol: A molecule whose time has come? And gone?
  publication-title: Clin Biochem
  doi: 10.1016/S0009-9120(96)00155-5
– volume: 15
  start-page: 3145
  year: 2014
  ident: key20180107175716_b4-ijo-50-03-0873
  article-title: Autophagic cell death and cancer
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms15023145
– volume: 371
  start-page: 347
  year: 2016
  ident: key20180107175716_b33-ijo-50-03-0873
  article-title: Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.11.032
SSID ssj0025501
Score 2.5586035
Snippet Resveratrol is known to be an effective chemo-preventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer...
Resveratrol is known to be an effective chemopreventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer...
SourceID proquest
gale
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 873
SubjectTerms Amino Acid Chloromethyl Ketones - pharmacology
AMP-Activated Protein Kinases - metabolism
Antineoplastic Agents - pharmacology
Antineoplastic Agents, Phytogenic - pharmacology
Apoptosis
Apoptosis - drug effects
Autophagy
Autophagy - drug effects
Autophagy-Related Protein 12 - genetics
Autophagy-Related Protein 5 - genetics
Beclin-1 - genetics
Cancer therapies
Care and treatment
Caspase 3 - metabolism
Caspase 9 - metabolism
Cell Line, Tumor
Cellular signal transduction
Chemotherapy
Cisplatin - pharmacology
Cytochrome
Cytoplasm
Deoxyribonucleic acid
Development and progression
DNA
DNA Fragmentation - drug effects
Drug Resistance, Neoplasm
Health aspects
Humans
Immunoglobulins
Kinases
Microtubule-Associated Proteins - genetics
Mitochondria
Morphology
Mouth cancer
Mouth Neoplasms - pathology
Oral cancer
Penicillin
Phosphorylation - drug effects
Proteins
Proto-Oncogene Proteins c-akt - metabolism
Resveratrol
RNA, Messenger - genetics
Rodents
Signal Transduction - drug effects
Stilbenes - pharmacology
TOR Serine-Threonine Kinases - metabolism
Title Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling
URI https://www.ncbi.nlm.nih.gov/pubmed/28197628
https://www.proquest.com/docview/1957649266
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxAvE98UxvADghes4tSJa15QmDZNoJaq2qS-Wf7KVBhJ1mRI_An819wlbqtOgker1zbt3fl-Z9_9jpA36VgKb7MPTFku8JpRMqMyxxSyywUvrHeYKE6m2dmF-LJIF_HArYllles9sduofeXwjHzIFSBjZLfLPtXXDKdG4e1qHKFxl-wjdRmWdMnFNuEC9N0lXABjGEbenmMTQnQyXH7Hzj8uYdURJG5j0u2d-Rbe7OLO6QNyEAEjzXsNPyR3QvmI3JvEK_HH5M88NL-QGXlVXTFIsEFVnpob5Aswl7-pKWFVV3VbNcuGLkvqlk2N9W8lg0QbwWPZ0m5QH8VeferQClb0OJ9TPNNvPtKcgp9TrEKkVUHzyexr96H5j3b48_zbnGIFiMGm9ifk4vTk_PiMxfkKzKWJaFkWRtKHMBKJt2kaDFdFBukQdzwoHySET4mnHJ4ra5QALFB4ITPDUwcgyiej0VOyV1ZleE4opLqF9WmwngdR2GCzbBykT4TBDCiEAXm__oe1i-TjOAPjSkMSggrRoBCNCtGokAF5uxGve9aNfwm-RnXpvml04606FwpZhADfDMi7TgL9Fb7Rmdh2AM-NzFc7koc7kuBnbvfltUno6OeN3lrlgDzrzWTzwHhFCaFm_OL_b3xJ7uPP6evaDsleu7oJrwDotPaos-Yjsv_5ZDqbw2o6m_wFtHz9mA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqQRcEG9SCt0DjwurYGdtx0gImdIqJU2oolTqbdlXUGixTeyC-hP4M_xGZvxIlUpw69HyJn7M7Mx8nplvAJ4Hg0hYHb7hsfYEpRkjruLQ8JjY5ZwV2hoCiuNJODwWn06Ckw340_bCUFllaxMrQ20zQ9_Ie16MkTGx24Xv8x-cpkZRdrUdoVGrxchd_ELIVrw7-IjyfeH7-3uz3SFvpgpwE_ii5KHrR9a5vvCtDgKnvHgeIgjwjOdi6yJ0GhFhe-vFWsUCPeDciihUXmAwdLA-fQBFk78p-ghlOrD5YW9yNF1BPIz3K4iHgRMnX1-zemJQ4PcW36jX0IvwqKJkvPSCV33BlQi38nT7d-B2E6KypNapu7Dh0ntwY9wk4e_D76krfhIX8zI74wjpUTksU-fEUKC-XjCV4lGe5WVWLAq2SJlZFDlV3KUcoT2Fq2nJqtGAjNgBmCG9W7LdZMooi1C8ZQlDy8Ko7pFlc5aMj0bVnyanZe_77POUUc2Jojb6B3B8Le_-IXTSLHWPgSG4nmsbOG09J-ba6TAcuMj6QhHmcq4Lr9s3LE1Dd05TN84kwh4SiESBSBKIJIF04eVqeV7zfPxr4Q6JS9Ztqiv7IBMRE28RRlRdeFWtIAuBVzSqaXTA-yaurbWV22srcWeb9dOtSsjGshTych904VGtJqsbpqQoOrfB1v9_uAM3h7PxoTw8mIyewC16tLqqbhs65fLcPcUwq9TPGt1m8OW6t9NfVRM5GA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRaq4IN6EFroHHhdWYZ21N0ZCyGqJWkJKFbVSbsu-XAVa28QuqD-Bv8SvY8aPRKkEtx4tb-LHzM7M55n5hpAX4VAKZ6K3LDZcYJpRMh1HlsXILuedMM4iUJwcRQen4tMsnG2QP10vDJZVdjaxNtQut_iNvM9jiIyR3S7qp21ZxPH-6EPxg-EEKcy0duM0GhUZ-6tfAN_K94f7IOuXQTD6eLJ3wNoJA8yGgahY5AfSeT8QgTNh6DWP0wgAAbfcx85LcCAScb7jsdGxAG-YOiEjzUMLYYQL8GMomP9bchBy3GNytgJ7EPnXYA9CKIZev-H3hPAg6M-_Ydchl3BUkzOu_OF1r3At1q193uguudMGqzRptOse2fDZfbI1adPxD8jvqS9_IivzIj9nAO5BTRzVl8hVoM-uqM7gqMiLKi_nJZ1n1M7LAmvvMgYgHwPXrKL1kECKPAHUogYu6F4ypZhPKN_RhIKNoVgBSfOUJpPjcf2nyfeqf3HyZUqx-kRjQ_1Dcnojb_4R2czyzD8hFGB2alzojeNepMabKBp66QKhEX153yNvujesbEt8jvM3zhUAIBSIAoEoFIhCgfTIq-XyomH8-NfCXRSXahpWl5ZCJSJGBiOIrXrkdb0CbQVc0eq25QHuG1m31lburK2EPW7XT3cqoVobU6rVjuiRx42aLG8Y06Pg5oZP___DXbIFm0h9Pjwab5Pb-GRNed0O2awWl_4ZxFuVeV4rNiVfb3on_QWEtDvo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Resveratrol-induced+autophagy+and+apoptosis+in+cisplatin-resistant+human+oral+cancer+CAR+cells%3A+A+key+role+of+AMPK+and+Akt%2FmTOR+signaling&rft.jtitle=International+journal+of+oncology&rft.au=Chang%2C+Chao-Hsiang&rft.au=Lee%2C+Chao-Ying&rft.au=Lu%2C+Chi-Cheng&rft.au=Tsai%2C+Fuu-Jen&rft.date=2017-03-01&rft.issn=1019-6439&rft.eissn=1791-2423&rft.volume=50&rft.issue=3&rft.spage=873&rft.epage=882&rft_id=info:doi/10.3892%2Fijo.2017.3866&rft.externalDBID=n%2Fa&rft.externalDocID=10_3892_ijo_2017_3866
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1019-6439&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1019-6439&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1019-6439&client=summon